Drugs

The Challenges and Risks of Adopting Foreign Price Controls

4 hours ago   |   BIOtechNow

The Trump Administration is moving forward with a plan to import foreign price controls into Medicare. Under the proposed International Pricing Index model, the federal...
Read more ...

Programmable swarmbots make flexible biological tools

8 hours ago   |   ScienceDaily

Biomedical engineers have developed a new platform to create biological drugs using specially engineered bacteria that burst and release useful proteins when they sense that...
Read more ...

Amplyx Inks Novartis Deal for Another Compromised-Immune System Drug

Amplyx Inks Novartis Deal for Another Compromised-Immune System Drug

12 hours ago   |   Xconomy

Amplyx Pharmaceuticals, which is testing a new type of drug against life-threatening infections acquired by patients with compromised immune systems, has acquired the rights to...
Read more ...

A near infrared light-triggerable modular formulation for the delivery of small biomolecules

12 hours ago   |   Journal of Nanobiotechnology

Externally triggered drug delivery systems hold considerable promise for improving the treatment of many diseases, in particular, diseases where the spatial-temporal release of...
Read more ...

FDA Awards AnaBios Grant to Further Develop Preclinical Assay Using Human Primary Cardiomyocytes

14 hours ago   |   San Diego Biotechnology

SAN DIEGO, Sept. 17, 2019 /PRNewswire/ - The U.S. Food and Drug Administration has named AnaBios the recipient of a grant to further develop its unique drug discovery platform...
Read more ...

Prostate drug may slow Parkinson's progression, big data suggest

1 day ago   |   Fierce Biotech

Terazosin, a decades-old drug to treat enlarged prostate, could provide a new way to address Parkinson's disease by targeting PGK1, scientists at Capital Medical University in...
Read more ...

Lundbeck Paying Nearly $2B for Alder to Follow Migraine Rivals to Market

Lundbeck Paying Nearly $2B for Alder to Follow Migraine Rivals to Market

1 day ago   |   Xconomy

Denmark's neuroscience-focused pharma firm Lundbeck has agreed to pay $1.95 billion to acquire Seattle-based Alder BioPharmaceuticals to boost its late-stage pipeline and...
Read more ...

Erasca, Inc.: Sr. Scientist, Chemistry

1 day ago   |   San Diego Biotechnology

Erasca, Inc.: Play a vital role in the discovery of novel, proprietary clinical candidates to consolidate ERASCA into a lead drug discovery oncology company. San Diego, CA ...
Read more ...

J&J taps AlivaMab for multi-target antibody discovery effort

1 day ago   |   Fierce Biotech

Johnson & Johnson has tasked AlivaMab Discovery Services with finding antibody-drug candidates against multiple targets. The project is built on the AlivaMab Mouse platform...
Read more ...

Foghorn and Rgenix nab Agios, Roche veterans as new CMOs

1 day ago   |   Fierce Biotech

Smaller biotechs are continuing their biopharma hiring spree as two startups nab some big names for their aspiring cancer drug research.
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Why Menlo Ventures Backed Its First Construction Tech Firm

Why Menlo Ventures Backed Its First Construction Tech Firm

Fieldwire , whose mobile app helps builders and construction crews coordinate their work, announced today it has lined up a total of $33.5 million across two newly disclosed... Read more ...

HMS's $36M Deal to Buy VitreosHealth Combines Complementary Firms

HMS's $36M Deal to Buy VitreosHealth Combines Complementary Firms

One Texas-based healthcare software business has acquired another in an all-cash deal worth $36.5 million, the companies announced late Monday. Irving, TX-based HMS Holdings... Read more ...

ESnet a Key Partner on Project to Build Novel Network Research Infrastructure

ESnet a Key Partner on Project to Build Novel Network Research Infrastructure

Anticipated FABRIC topology at the end of construction. The National Science Foundation is funding a collaborative effort to create a nationwide research infrastructure that... Read more ...

Automated Trucking Company TuSimple Adds $120M More From Investors

Automated Trucking Company TuSimple Adds $120M More From Investors

UPS, the global package delivery giant, took a minority stake this summer in TuSimple, a self-driving trucking company, but didn't reveal financial details. On Tuesday, the San... Read more ...

Amplyx Inks Novartis Deal for Another Compromised-Immune System Drug

Amplyx Inks Novartis Deal for Another Compromised-Immune System Drug

Amplyx Pharmaceuticals, which is testing a new type of drug against life-threatening infections acquired by patients with compromised immune systems, has acquired the rights to... Read more ...

Lundbeck Paying Nearly $2B for Alder to Follow Migraine Rivals to Market

Lundbeck Paying Nearly $2B for Alder to Follow Migraine Rivals to Market

Denmark's neuroscience-focused pharma firm Lundbeck has agreed to pay $1.95 billion to acquire Seattle-based Alder BioPharmaceuticals to boost its late-stage pipeline and... Read more ...

KATRIN Cuts the Mass Estimate for the Elusive Neutrino in Half

KATRIN Cuts the Mass Estimate for the Elusive Neutrino in Half

A diagram of the layout and major features of the KATRIN experimental facility at the Karlsruhe Institute of Technology. (Credit: Karlsruhe Institute of Technology) Note: This... Read more ...

INmune Bio Invited to Speak on Company's Advancements in Cancer Treatments...

La Jolla, CA., Sept. 17, 2019 - INmune Bio, Inc. , an immunology company focused on developing treatments that harness the patient's innate immune system to fight disease... Read more ...

Equillium to Host Business Update Call on October 1, 2019

LA JOLLA, Calif., Sept. 17, 2019 - Equillium, Inc. , a clinical-stage biotechnology company, leveraging deep understanding of immunobiology to develop products to treat severe... Read more ...

AXIM® Biotechnologies Announces Cultivation Agreement to Establish Company's...

SAN DIEGO, Sept. 17, 2019 - AXIM® Biotechnologies, Inc. (“AXIM® Biotech,” “AXIM” or “the Company”) , a world leader in cannabinoid research and development, today announced... Read more ...